UZRASNO I POLNO SPECIFIČNE KARAKTERISTIKE OBOLELIH OD COVID-19 U AUTONOMNOJ POKRAJINI VOJVODINI U 2020. GODINI

  • Nikolina Tešić Univerzitet u Novom Sadu, Medicinski fakultet
  • Snežana Medić Univerzitet u Novom Sadu, Medicinski fakultet; Institut za javno zdravlje Vojvodine
DOI: https://doi.org/10.5937/mp74-39441
Ključne reči: COVID-19; SARS-CoV-2; pol; starost; težina bolesti;

Sažetak


Uvod: Kliničke manifestacije koronavirusne bolesti-2019 (engl. Coronavirus disease 2019- COVID-19) variraju od asimptomatskih do teških kliničkih oblika. Činioci koji utiču na nepovoljan tok bolesti, uključujući pol i uzrast obolelih, se još uvek proučavaju.

Cilj rada: Utvrditi polne i uzrasno specifične karakteristike obolelih od COVID-19 u periodu od marta do decembra 2020. godine na teritoriji Autonomne pokrajine Vojvodine.

Materijal i metode: Za obradu podataka korišćen je deskriptivni metod. Podaci o laboratorijskim potvrđenim slučajevima COVID-19 su preuzeti iz baze epidemiološkog nadzora Instituta za javno zdravlje Vojvodine i analizirani retrospektivno. Prema težini bolesti, slučajevi su klasifikovani kao: asimptomatski, blagi, teški ili kritični. Registrovani slučajevi COVID-19 su analizirani po polu i uzrastu u odnosu na težinu kliničke slike, a rezultati su prikazani tabelarno i grafički.

Rezultati: U posmatranom periodu registrovano je ukupno 78106 slučajeva COVID-19 (incidencija 4217/100.000). Posmatrano po polu, 50,8% obolelih su bili ženskog pola. Najviša uzrasno specifična stopa incidencije COVID-19 je registrovana u uzrastu od 30 do 59 godina (5876/100.000). Teška i kritična forma COVID-19 bila je češća u uzrastu ≥ 60 godina života (18,0-39,0%). Asimptomatski tok bolesti je zastupljeniji kod najstarijih ≥80 godina (16,0%) i najmlađih <9 godina života (13,0%). Specifična stopa incidencije COVID-19 bila je 1,6-2,4 puta viša kod muškaraca kada je reč o teškim i kritičnim formama bolesti.

Zaključak:  U ranoj fazi pandemije COVID-19, težina kliničke slike je varirala u odnosu na pol i uzrast obolelih. Najviše je bilo pogođeno odraslo radno aktivno stanovništvo ali su teže i životno ugrožavajuće forme bolesti češće registrovane kod najstarijih pacijenata predominantno muškog pola.

Ključne reči: COVID-19; SARS-CoV-2; pol; starost; težina bolesti;                                                  

Biografija autora

Snežana Medić, Univerzitet u Novom Sadu, Medicinski fakultet; Institut za javno zdravlje Vojvodine

Ass dr sc med Snežana Medić, Prim1,2 (Šef Odseka za epidemiološki nadzor, kontrolu i prevenciju zoonoza, vektorskih i crevnih zaraznih bolesti)

1-Univerzitet u Novom Sadu, Medicinski fakultet

2-Institut za javno zdravlje Vojvodine

Reference


  1. Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020;7(1):11.

  2. Lotfi M, Hamblin MR, Rezaei N. COVID-19: Transmission, prevention, and potential therapeutic opportunities. Clin Chim Acta. 2020;508:254-266.

  3. World Health Organisation [homepage on the Internet]. Coronavirus disease (COVID-19) pandemic. About the virus [updated 2021 April 14; cited 2021 October 31]. Available from: https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/novel-coronavirus-2019-ncov.

  4. World Health Organisation [homepage on the Internet]. Тhe impact of COVID-19 on global health goals [updated 2021 May 20; cited 2022 January 20]. Available from: https://www.who.int/news-room/spotlight/the-impact-of-covid-19-on-global-health-goals.

  5. Ristić M, Milosavljević B, Vapa S, Marković M, Petrović V. Seroprevalence of antibodies against SARS-CoV-2 virus in Northern Serbia (Vojvodina): A four consecutive sentinel population-based survey study. PLoS One. 2021;16(7):e0254516.

  6. Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features. Evaluation, and Treatment of Coronavirus (COVID-19). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; [Updated 2022 Jan 5; cited 2022 January 22]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK554776/.

  7. Ristić M, Nikolić N, Čabarkapa V, Turkulov V, Petrović V. Validation of the STANDARD Q COVID-19 antigen test in Vojvodina, Serbia. PLoS One. 2021;16(2):e0247606.

  8. Haleem A, Javaid M, Vaishya R. Effects of COVID-19 pandemic in daily life. Curr Med Res Pract. 2020;10(2):78-79.

  9. World Health Organisation [homepage on the Internet]. Impact of COVID-19 on people's livelihoods, their health and our food systems [updated 2020 October 13; cited 2022 January 10]. Available from: https://www.who.int/news/item/13-10-2020-impact-of-covid-19-on-people's-livelihoods-their-health-and-our-food-systems.

  10. Davies NG, Klepac P, Liu Y, Prem K, Jit M, CMMID COVID-19 working group, et al. Age-dependent effects in the transmission and control of COVID-19 epidemics. Nat Med. 2020;26(8):1205-1211.

  11. Ancochea J, Izquierdo JL, Soriano JB. Evidence of Gender Differences in the Diagnosis and Management of Coronavirus Disease 2019 Patients: An Analysis of Electronic Health Records Using Natural Language Processing and Machine Learning. J Womens Health (Larchmt). 2021;30(3):393-404.

  12. Nekaeva ES, Bolshakova AE, Malysheva ES, Galova EA, Makarova EV, Nekrasova TA, et al. Gender Characteristics of the Novel Coronavirus Infection (COVID-19) in Middle-Aged Adults. Sovrem Tekhnologii Med. 2021;13(4):16-24.

  13. Statistical Office of the Republic of Serbia. Population estimates for 2019. Belgrade 2019. [updated 2021 December 23; cited 2022 January 12] Available from: https://publikacije.stat.gov.rs/G2020/Pdf/G20201172.pdf.

  14. Galanti M, Birger R, Ud-Dean M, Filip I, Morita H, Comito D, et al. Rates of asymptomatic respiratory virus infection across age groups. Epidemiol Infect. 2019;147:e176.

  15. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. 2020;395(10229):1054-1062.

  16. Yoon S, Li H, Lee KH, Hong SH, Kim D, Im H, et al. Clinical Characteristics of Asymptomatic and Symptomatic Pediatric Coronavirus Disease 2019 (COVID-19): A Systematic Review. Medicina (Kaunas). 2020;56(9):474.

  17. Wyper GMA, Assunção R, Cuschieri S, Devleesschauwer B, Fletcher E, Haagsma JA, et al. Population vulnerability to COVID-19 in Europe: a burden of disease analysis. Arch Public Health. 2020 Jun 18;78:57. Corrected and republished from: Arch Public Health. 2020;78:47.

  18. Cinislioglu AE, Cinislioglu N, Demirdogen SO, Sam E, Akkas F, Altay MS et al. The relationship of serum testosterone levels with the clinical course and prognosis of COVID-19 disease in male patients: A prospective study. Andrology. 2022;10(1):24-33.

  19. Porcheddu R, Serra C, Kelvin D, Kelvin N, Rubino S. Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China. J Infect Dev Ctries. 2020;14(2):125-128.

  20. Wenham C, Smith J, Morgan R; Gender and COVID-19 Working Group. COVID-19: the gendered impacts of the outbreak. Lancet. 2020;395(10227):846-848.

  21. Rod JE, Oviedo-Trespalacios O, Cortes-Ramirez J. A brief-review of the risk factors for covid-19 severity. Rev Saude Publica. 2020;54:60.

  22. Bajaj V, Gadi N, Spihlman AP, Wu SC, Choi CH, Moulton VR. Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections? Front Physiol. 2021;11:571416.

Objavljeno
2024/02/22
Broj časopisa
Vol. 74 Br. 5 (2023): Medicinski podmladak
Rubrika
Originalni naučni članak